Cited by 1,058Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCancer Genomics and Diagnostics

The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.

Natural selection of tumor variants in the generation of “tumor escape” phenotypes

Open access

Khong, Hung T., Restifo, Nicholas P.·2002·Nature Immunology

Open this paper in CoChat — free account

Abstract

The idea that tumors must "escape" from immune recognition contains the implicit assumption that tumors can be destroyed by immune responses either spontaneously or as the result of immunotherapeutic intervention. Simply put, there is no need for tumor escape without immunological pressure. Here, we review evidence supporting the immune escape hypothesis and critically explore the mechanisms that may allow such escape to occur. We discuss the idea that the central engine for generating immunoresistant tumor cell variants is the genomic instability and dysregulation that is characteristic of the transformed genome. "Natural selection" of heterogeneous tumor cells results in the survival and proliferation of variants that happen to possess genetic and epigenetic traits that facilitate their growth and immune evasion. Tumor escape variants are likely to emerge after treatment with increasingly effective immunotherapies.

Integrity signals

Registry

Crossref · 10.1038/ni1102-999

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J., Lanier, L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 3,272
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,548
A cell culture model for T lymphocyte clonal anergy
Schwartz, R. H. (1990) · Science · doi:10.1126/science.2113314 · Cited by 1,857
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., & Sakaguchi, S. (2002) · Nature Immunology · doi:10.1038/ni759 · Cited by 1,729
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
Sakaguchi, S., Sakaguchi, N., Shimizu, J., Yamazaki, S., Sakihama, T., Itoh, M., Kuniyasu, Y., Nomura, T., Toda, M., & Takahashi, T. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820102.x · Cited by 1,505
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
CD4+CD25+ Immunoregulatory T Cells
McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M., & Byrne, M. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00280-7 · Cited by 1,395
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P. J., Schreier, M. H., French, L. E., Schneider, P., Bornand, T., Fontana, A., Liénard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,236

Show all 104 references

Sorted by citations

Items 801–900 of 998

Niche engineering drives early passage through an immune bottleneck in progression to colorectal cancerPreprint
Gatenbee, C., Baker, A., Schenck, R. O., Neves, M. P., Hasan, S. Y., Martinez, P., Cross, W. C. H., Jansen, M., Rodriguez‐Justo, M., Sottoriva, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/623959 · Cited by 4
Immunosuppressive niche engineering at the onset of human colorectal cancerPreprint
Gatenbee, C., Baker, A., Schenck, R. O., Strobl, M. A. R., West, J., Neves, M. P., Hasan, S., Lakatos, E., Martinez, P., Cross, W. C. H., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-799879/v1 · Cited by 4
Innate immunity in tumour immunoediting and immunosurveillance
Zhang, Z., Zhang, Y., & Lieberman, J. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00650-7 · Cited by 4
Advancing adoptive T cell therapy in ovarian cancer: barriers, innovations, and emerging platforms
Santos, G. N. D. S., DeJohn, C. R., Hess, S. M., Zsíros, E., & McGray, A. R. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013285 · Cited by 3
Modulation of Tumor Microenvironment via Antibody Mediated Precision Delivery of CpG to Myeloid Cell
Xiang, Y., Hao, X., Li, H., Ma, Z., Ma, Z., Ji, L., Yang, Z., Wang, J., Chen, M., & Baigude, H. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03629 · Cited by 3
Capturing Hydrophilic Chemotherapeutics Agents Into siRNA‐Encapsulated Vesicle‐Like Nanoparticles for Convenient ICB‐Chemo Combination Therapy
Li, Y., Li, B., Chen, C., Hou, H., Su, M., Li, F., Xiao, Z., & Yang, X. (2024) · Small · doi:10.1002/smll.202404073 · Cited by 3
Gastric Cancer Immunotherapy: An Overview
Romano, F., Uggeri, F., Nespoli, L. C., Gianotti, L. V., Garancini, M., Maternini, M., Nespoli, A., & Uggeri, F. (2013) · Journal of Cancer Therapy · doi:10.4236/jct.2013.45116 · Cited by 3
Immune Signature of Malignant Pleural Mesothelioma as Assessed by Transcriptome Analysis.
Mohr, S., Neuville, A., Bottin, M. C., Micillino, J. C., Keith, G., & Rihn, B. H. (2005) · PubMed · Cited by 3
Selection of tumor‑resistant variants following sustained natural killer cell‑mediated immune stress
Carré, T., Thiery, J., Janji, B., Terry, S., Gros, G., Meurice, G., Kiéda, C., Olive, D., & Chouaı̈b, S. (2020) · Oncology Reports · doi:10.3892/or.2020.7872 · Cited by 3
Comparing immunotherapies to other frequently used treatments of gastric cancer
Basile, D., Simionato, F., Calvetti, L., Cappetta, A., Pesavento, A., Mongillo, M., Roviello, G., Rosati, G., Rossi, G., & Aprile, G. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1938546 · Cited by 3
Mechanism, Challenges, and Progresses of Chimeric Antigen Receptors T-cell Cancer Therapy
Hussein, A., & Edao, B. M. (2024) · Journal of Cellular Immunology · doi:10.33696/immunology.6.190 · Cited by 2
Advanced materials for combined photodynamic and immunotherapy: Mechanisms and translational opportunities
Zou, S., Hu, K., Guo, X., Bu, L., Qiu, H. G., & Wu, Q. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.164487 · Cited by 3
Immune Escape: Immunosuppressive Networks
Wei, S., Chang, A. E., & Zou, W. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50070-5 · Cited by 3
Репрограммированые in vitro на М3 фенотип макрофаги останавливают рост солидной карциномы in vivo
Раецкая, А. А., Валерьевич, К. С., Владимировна, Л. С., Малышева, Е. В., Буданова, О. П., Bakhtina, L. Y., & Malyshev, I. Y. (2018) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2018.01.41-46 · Cited by 3
Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor
Missale, G., & Cariani, E. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.72 · Cited by 3
NIPS, a 3D network-integrated predictor of deleterious protein SAPs, and its application in cancer prognosis
Wang, B., Li, J., Cheng, X., Zhou, Q., Yang, J., Zhang, M., Chen, H., & Li, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-24286-2 · Cited by 3
Classical and alternative activation of macrophages: different pathways of macrophage-mediated tumor promotion
Ginderachter, J. A. V., Liu, Y., Devoogdt, N., Noël, W., Brys, L., Gh., G. H., Raes, G., Geldhof, A. B., Beschin, A., Revets, H., et al. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6729-7_9 · Cited by 3
Identification of candidate genes with pro-apoptotic properties by functional screening of randomly fragmented CDNA libraries
Hassan, M., Matuschek, C., Gerber, P. A., Peiper, M., Budach, W., & Bölke, E. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-4-162 · Cited by 3
Blocking HIF-1α Following Radiotherapy to Prolong and Enhance the Immune Effects of Radiotherapy: A Hypothesis
Ming, P. (2014) · Medical Science Monitor · doi:10.12659/msm.891048 · Cited by 3
Descriptive Dermoscopic Study of Depigmentation in Melanocytic Nevi Without a Visible Halo
Martín, J. M., Núñez, J. E., López, V., Rubio, M., Monteagudo, C. C., & Jordá, E. (2011) · Actas Dermo-Sifiliográficas · doi:10.1016/s1578-2190(11)70817-4 · Cited by 3
Immunotherapy and Radiation Therapy for Non-Small Cell Lung Cancer—A Stimulating Partnership
van Dams, R., Yuan, Y., Robinson, C. G., & Lee, P. P. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-3399578 · Cited by 3
Future directions for vaccine-based therapies
Vieweg, J. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.08.012 · Cited by 3
Response to Comment on “Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma”
Rosenberg, S. A., & Restifo, N. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4511-a · Cited by 3
Self-citation
Closed-loop sonothermogenetic control of CAR T cells for metronomic brain cancer therapyPreprint
Zamat, A. H., Kim, C., Sridhar, S., Fábrega, S., Sen, R., Campbell, N., Oliver, S. A., Zha, Z., Thiveaud, C. A., Kulaksizoglu, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.23.650339 · Cited by 3
Liquid-liquid phase separation drives immune signaling transduction in cancer: a bibliometric and visualized study from 1992 to 2024
Pei, Y., Liang, H., Guo, Y., Wang, B., Wu, H., Jin, Z., Lin, S., Zeng, F., Wu, Y., Shi, Q., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1509457 · Cited by 2
Tumor immune microenvironment in adenoid cystic carcinoma of the lacrimal gland: relationship with histopathology and prognosis
Zhang, Y., Guo, Z., Sun, J., Bi, Y., Cai, R., Zhang, R., Ren, H., Qian, J., & Meng, F. (2025) · BMC Cancer · doi:10.1186/s12885-025-13438-z · Cited by 2
Lymphodepleting preconditioning impairs host antitumor immunity induced by adoptive T cell therapy in mouse models
Figueroa, D. A., Vega, J. P., Hernández‐Oliveras, A., Ardiles, F., Hidalgo, S., López, X., Saavedra, V., Bustamante, C., Malavé, D. A. G., Flores‐Santibáñez, F., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71082-y · Cited by 2
Flow Cytometry Enumeration of Apoptotic Cancer Cells by Apoptotic Rate
Díaz, D., I, A. P., Reyes, E., Barcenilla, H., Monserrat, J., & Álvarez‐Mon, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-339-4_3 · Cited by 2
A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of TOP1MT
Fei, L., Lu, Z., Xu, Y., & Hou, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.920897 · Cited by 2
Prognostic value of pretreatment lymphocyte percentage in oral cancer: A prospective cohort study
Wang, N., Lin, Y., Shen, L., Song, H., Huang, W., Huang, J., Chen, F., Liu, F., Wang, J., Qiu, Y., et al. (2023) · Oral Diseases · doi:10.1111/odi.14658 · Cited by 2
Exploring Biocomplexity in Cancer: A Comprehensive Review
Szász, A., & Szigeti, G. P. (2024) · Open Journal of Biophysics · doi:10.4236/ojbiphy.2024.142009 · Cited by 2
Engineering DNA Vaccines for Cancer Therapy
Olson, B. M., & McNeel, D. G. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4372-7_17 · Cited by 2
Myeloid-Derived Suppressor Cells and Tumor Growth
Raffaghello, L., & Bianchi, G. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4_5 · Cited by 2
Tumor Antigens Revealed by Exome Seqeuncing Drive Editing of Tumor Immunogenicity
Vesely, M. D. (2013) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7c8278n · Cited by 1
Cancer rejection by the immune system: Forcing the check-points of tumor immune escape
D, S. M. M., Mandruzzato, S., Zanovello, P., & Bronte, V. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.016 · Cited by 2
Relapse of melanoma after successful adoptive T‐cell therapy: escape through inflammation‐induced phenotypic melanoma cell plasticity
Somasundaram, R., & Herlyn, M. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12038 · Cited by 2
Cancer immunoediting and dioxin-activating aryl hydrocarbon receptor: a missing link in the shift toward tumor immunoescape?
Ridolfi, R., Guidoboni, M., & Ridolfi, L. (2010) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2010.e6 · Cited by 4
Cancer Metabolic Phenotype
Griffiths, J. R., & Stubbs, M. (2007) · Humana Press eBooks · doi:10.1385/1-59259-893-5:135 · Cited by 2
Dissecting the pathways of tumour escape: " question of life and death?"
Tchernev, G., & Nenoff, P. (2010) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962010000200022 · Cited by 2
Tumor Growth is Stimulated by Muscarinic Receptor Agonism: Role of Autoantibodies in Breast Cancer Patients
Sales, M. E. (2012) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/187152212802001839 · Cited by 2
Brain Tumors and Inflammation
Irshad, K., Madan, E., & Chosdol, K. (2016) · Springer eBooks · doi:10.1007/978-981-10-1711-7_10 · Cited by 2
Immune Response in Melanoma: A Basis to Understand the Role of Immunotherapy with Immune Checkpoint Inhibitors
Pires, E. M., & Moura, C. (2018) · Journal of the Portuguese Society of Dermatology and Venereology · doi:10.29021/spdv.76.1.868 · Cited by 2
Molecular pathologic mechanisms of neoplastic diseases
Pehlivanoğlu, B., Aysal, A., Ekmekçi, S., Şahin, Y., Toper, M. H., Gündoğdu, B., Erdogdu, I., & Talu, C. (2019) · Journal of Current Pathology · doi:10.5146/jcpath.2019.48 · Cited by 2
Salmonella-based Anticancer Vaccines and their Efficacy
Bonab, S. F., & Khansari, N. (2019) · Vaccination Research – Open Journal · doi:10.17140/vroj-4-111 · Cited by 2
Modulating the innate immune activity in murine tumor microenvironment by a combination of inducer molecules attached to microparticles
Shahar, E., Gorodetsky, R., Aizenshtein, E., Lalush, L., & Pitcovski, J. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1719-z · Cited by 2
Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma
Akazawa, Y., Suzuki, T., Yoshikawa, T., Mizuno, S., Nakamoto, Y., & Nakatsura, T. (2019) · World Journal of Meta-Analysis · doi:10.13105/wjma.v7.i3.80 · Cited by 2
Antigen Processing and Presentation
Eisenlohr, L. C., & Rothstein, J. L. (2007) · Springer eBooks · doi:10.1007/0-387-27545-2_1 · Cited by 2
Attenuation of Immune Suppression to Complement Glioma Immunotherapy
Field, C. S. (2016) · doi:10.26686/wgtn.17013761.v1 · Cited by 2
Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer
Zhang, H., Zhang, X., Zhang, Y., Han, D., Ha, H., Zhang, B., & Shang, P. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01149-y · Cited by 1
Immunohistochemical expression of tumor-infiltrating lymphocytes CD8 and FOXP3 in invasive ductal carcinoma of breast
Fathima, Z. S., Suresh, T. N., & Kattepur, A. K. (2025) · BMC Cancer · doi:10.1186/s12885-025-14892-5 · Cited by 1
Metabolomic profiling and anti-tumor function of canine NK cells in tumor interaction
He, S., Wu, S., Chen, L., Li, Y., & Wang, B. (2026) · BMC Veterinary Research · doi:10.1186/s12917-026-05343-9 · Cited by 1
VEGF/VEGFR targeting-induced vascular normalization: a key strategy to reverse cold tumor phenotype and potentiate immunotherapy in gynecologic cancers
Wang, Y., MaoYan, T., Peng, C., Yang, J., Liu, F., Ding, D., Guo, Y., Yu, Y., & Han, F. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116821 · Cited by 2
Integrating Bulk and Single‐Cell RNA‐Seq Reveals Glycolysis‐Associated Macrophages and Its Related Tumor Subgroup Signatures to Predict Prognosis and Therapy in Clear Cell Renal Cell Carcinoma
Li, Y., Chen, Y., Wang, L., Yuan, S., Wu, L., Sun, H., Wang, D., & Lv, H. (2026) · Human Mutation · doi:10.1155/humu/3125551 · Cited by 1
Investigating the Consequences of Aneuploidy in Cancer and Normal Tissue
Modi, J. N., & Taylor, A. M. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-22637-2_15 · Cited by 1
Gold(I)-Loaded Nanomedicine for Liver Cancer: A Closed-Loop Strategy Integrating Ferritinophagy-Driven Ferroptosis and Immunotherapy
Zhu, Y., Li, Y., Jiang, Y., Fan, Z., & Liu, W. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00899 · Cited by 1
Biomarkers for predicting and monitoring the efficacy of cancer vaccines
Remizova, J. A., Volkova, A. G., Makarova, A. S., Makarov, V. V., Yudin, V. G., & Keskinov, A. A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1904586 · Cited by 1
Immunological therapy in urological malignancy: Novel combination strategies
Finley, D. S., Pouliot, F., Chin, A. I., Shuch, B. M., Pantuck, A. J., Belldegrun, A. S., & deKernion, J. B. (2010) · International Journal of Urology · doi:10.1111/j.1442-2042.2010.02664.x · Cited by 1
Fast-Lane Evolution in the Tumor Microenvironment
Marincola, G., & Marincola, F. M. (2006) · Humana Press eBooks · doi:10.1385/1-59745-011-1:317 · Cited by 1
Pattern RT1A and proteasome expression in cellular fractions of Zajdela ascitic hepatoma
Melnikova, V. I., Захарова, Л. А., Хегай, И. И., & Ivanova, L. N. (2014) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672914040115 · Cited by 1
Role of Innate Immunity in Cancers and Antitumor Response
Jinushi, M., & Baghdadi, M. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_3 · Cited by 1
Psychoneuroimmunology and Cancer: Biobehavioral Influences on Tumor Progression
Lutgendorf, S. K., Costanzo, E. S., & Sood, A. K. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195394399.013.0019 · Cited by 1
A review on tumor immunology
Kaja, S., Kiran, S. V. N. S., Kattappagari, K. K., Chitturi, R., Chowdary, S., & Reddy, B. R. (2017) · Journal of Orofacial Sciences · doi:10.4103/0975-8844.207949 · Cited by 1
Hurdles in Cancer Immunotherapy
Sadeghi, F., Moghaddam, A. S., & Soleymanjahi, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_31 · Cited by 1
Immunopathology and Immunotherapy of Acute Lymphoblastic Leukemia
Stübig, T., & Kröger, N. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-57949-4_5 · Cited by 1
Immunologie et cancer: m�canismes d?�chappement tumoraux
Calmels, B. (2004) · ONCOLOGIE · doi:10.1007/s10269-005-0124-1 · Cited by 3
Immunomodulation
Arnaoutakis, K., Dorothy, A., Laura, F. A., & Kieber‐Emmons, T. (2013) · InTech eBooks · doi:10.5772/53667 · Cited by 1
Role of Immunity in Spontaneous Cure of Cancer
Tajamal, N. (2023) · American Journal of Medical and Clinical Research & Reviews · doi:10.58372/2835-6276.1090 · Cited by 1
Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden
Gorlov, I. P., Gorlova, O. Y., Tsavachidis, S., & Amos, C. I. (2024) · Scientific Reports · doi:10.1038/s41598-024-63468-z · Cited by 1
Immunopathology and Immunotherapy of Lymphoblastic Leukaemia
Stübig, T., & Kröger, N. (2015) · Springer eBooks · doi:10.1007/978-3-662-46410-6_6 · Cited by 1
Role of Kynurenine Pathway in Cancer Biology
Mowat, C. G. (2015) · Springer eBooks · doi:10.1007/978-3-319-11870-3_21 · Cited by 1
General Principles of Immunotherapy for Glioblastoma
Yang, A. I., Maus, M. V., & O’Rourke, D. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47660-7.00019-7 · Cited by 1
Programming the anti-tumor immune response in vitro and its application to stop the growth of tumor cells and prolonging the lifespan of mice with carcinoma in vivo
Валерьевич, К. С., Владимировна, Л. С., Раецкая, А. А., Буданова, О. П., & Malyshev, I. Y. (2017) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/igpp.2017.4.8525 · Cited by 1
An Introduction to CAR Immunotherapy
Balkhi, M. Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819573-4.00001-6 · Cited by 1
Genetic Alterations and Checkpoint Expression: Mechanisms and Models for Drug Discovery
Ding, S., Li, S., Zhang, S., & Li, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_10 · Cited by 1
М3 макрофаги останавливают деление клеток предстательной железы больного раком простаты
Валерьевич, К. С., Lyamina, S., Kuznetsova, L. V., Буданова, О. П., Малышева, Е. В., Говоров, А. В., Prilepskaya, E. A., Pushkar, D. Y., & Malyshev, I. Y. (2020) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2020.01.54-59 · Cited by 1
Immunology and Immunotherapy of Ovarian Cancer
Wilczyński, J. R., Nowak, M., & Wilczyński, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-57949-4_20 · Cited by 1
Tumor immune surveillance
Delitto, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87763-3.00015-0 · Cited by 2
Immunotherapy for Human Cancer
Cardoso, A. A., Haining, W. N., Leite, M., & Maia, S. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-664-5_16 · Cited by 1
Pulmonary Tumors Inefficiently Prime Tumor-Specific T Cells
O’Mara, L. A., & Allen, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.310 · Cited by 1
Immune Surveillance and Tumor Evasion
Jung, M. K. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0040-0_10 · Cited by 1
Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells
Popmihajlov, Z., Santori, F. R., Gebreselassie, D., Sandler, A. D., & Vukmanović, S. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0805-5 · Cited by 1
TAP-inhibitors from old world primate 1-herpesviruses and their use: WO2009008713
Raghavan, M. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903501563 · Cited by 1
The Interface of Metastatic Tumours and the Immune System
Muhsin, M.-R. K. (2012) · Otago University Research Archive (University of Otago) · Cited by 1
Inhibition of tumor growth by adenovirus-mediated expression of antiangiogenic and immunomodulatory proteins
Vijayshankar, S. G. (2006) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 1
Functional Cytotoxicity of T Cells in the Tumor Microenvironment
Lotem, M., Machlenkin, A., Frankenburg, S., & Peretz, T. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6750-1_8 · Cited by 1
Cancer therapy-induced immune modulation
Karl, J. C., & Mackall, C. L. (2005) · Cancer chemotherapy and biological response modifiers · doi:10.1016/s0921-4410(04)22015-4 · Cited by 1
An Overview of Acute Myeloid Leukemia and Cancer Immunology: (i) Concepts and Therapeutic Strategies and (ii) RepSox as a Candidate Cell-Engineering Tool
Jajosky, A. N. (2014) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.5874 · Cited by 1
Quiescent phenotype of tumor-specific CD8+T cells following immunization
Monsurrò, V., Wang, E., Yamano, Y., Migueles, S. A., Panelli, M. C., Smith, K., Nagorsen, D., Connors, M., Jacobson, S., & Marincola, F. M. (2003) · Cited by 1
MOLECULAR REGULATION OF THE TUMOR KILLING ACTIVITY OF DENDRITIC CELLS
Hanke, N. T. (2012) · UA Campus Repository (The University of Arizona) · Cited by 1
p53-Based Immunotherapy of Cancer
DeLeo, A. B. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-035-5_26 · Cited by 1
Targeted delivery of interferon-gamma by synNotch T cells sensitizes neuroblastoma cells to T cell-mediated killingPreprint
Cardenas, F. I., Weston, S., Avila, S. V., Zhou, H., Yousef, S., Fluchel, M. N., Morales, E., Olsen, M. L., Radhakrishnan, S. V., & Luetkens, T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.21.496901 · Cited by 1
Explanatory Puralism in Oncology: The Case of Neoantigen-Based Adoptive Cell Immunotherapies
Chiapperino, L., Graber, N., & Panese, F. (2023) · doi:10.5040/9781350281554.ch-008 · Cited by 1
HLA Class I Antigen-Processing Machinery and HLA Class I Antigen-Derived Peptide-Complex Defects in Tumor-Cell Escape
Campoli, M. R., Chang, C., Wang, X., & Ferrone, S. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-743-7_1 · Cited by 1
Engaging the Immune Response to Normalize the Tumor Microenvironment
Chi-Sabins, N., & Storkus, W. J. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Dynamic Nature of Tumour-Host Interactions Within the Tumor Microenvironment
Nagorsen, D., & Marincola, F. M. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_10
Mutagenesis, Malignancy and Genome Instability
Anderson, G. R., Stoler, D. L., & Bartos, J. D. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400033
Immunotherapy of Renal Cell Carcinoma – From Antigen Identification to Patient Treatment
Schuster, H., Walzer, M., & Eq, S. S. (2012) · InTech eBooks · doi:10.5772/26933
Cancer vaccine strategies and studies of human thioredoxin reductase splice variants
Dammeyer, P. (2010) · Figshare
Immunotherapy of Pancreatic Carcinoma: Recent Advances
Märten, A., & Büchler, M. W. (2009) · Frontiers of gastrointestinal research · doi:10.1159/000258293
Induction of T cell immunity overcomes resistance to PD-1 and CTLA-4 blockade and improves survival in pancreatic cancer
Winograd, R. (2015) · ScholarlyCommons (University of Pennsylvania)

Authors: Khong, H. T., & Restifo, N. P.
Affiliations: National Institutes of Health (US)
Corresponding author: Khong, Hung T.
Restifo, Nicholas P.
ORCID: Khong, Hung T.
Restifo, Nicholas P.
Venue: Nature Immunology
Publisher: Springer Science and Business Media LLC
Published: 2002-11
Volume: 3
Issue: 11
Pages: 999-1005
ISSN: 1529-2908 (ISSN-L)
1529-2916
DOI: 10.1038/ni1102-999
PMC: PMC1508168
OpenAlex: W2051940153
Cited by: 1,058
References: 104
Citations by year: 2026: 17 · 2025: 18 · 2024: 33 · 2023: 45 · 2022: 35 · 2021: 28 · 2020: 40 · 2019: 39 · 2018: 38 · 2017: 51 · 2016: 32 · 2015: 43 · 2014: 41 · 2013: 63 · 2012: 44
FWCI: 5.47
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Immunology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
University of Regensburg Publication Server (University of Regensburg)
Funders: National Institutes of Health (Z99 CA999999)
National Cancer Institute (Z01BC010763)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords: tumor immune evasion, natural selection, tumor heterogeneity, tumor variants, genomic instability, immunoresistance, epigenetic regulation, cancer immunotherapy resistance, immune evasion
MeSH terms: Animals, Antigens, Neoplasm, HLA Antigens, Humans, Immunologic Surveillance, Immunotherapy, Killer Cells, Natural, Neoplasms, Selection, Genetic, T-Lymphocytes, Cytotoxic, Immunodominant Epitopes, Cytokines, Apoptosis, Models, Immunological, Disease Progression, Tumor Escape, T-Lymphocytes, Regulatory, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Natural selection of tumor variants in the generation of “tumor escape” phenotypes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks